Singapore - English - HSA (Health Sciences Authority)

zyfas pharma pte ltd - atracurium besilate - injection, solution - 10.0 mg per ml - atracurium besilate 10.0 mg per ml

Kenya - English - Pharmacy and Poisons Board

hameln pharma plus p o box 10086331758hamelngermany - atracurium besilate - solution for injection - 10mg/ml - peripherally acting muscle relaxants:

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

hameln pharma ltd - atracurium besilate - solution for injection - 10mg/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

hameln pharma ltd - atracurium besilate - solution for injection - 10mg/1ml

Malta - English - Medicines Authority

hameln pharma limited nexus, gloucester business park, gloucester, united kingdom - atracurium besilate - solution for infusion or injection - atracurium besilate 10 mg/ml - muscle relaxants

Malta - English - Medicines Authority

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - atracurium besilate - solution for injection/infusion - atracurium besilate 10 mg/ml - muscle relaxants

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

idaman pharma sdn. bhd. - atracurium besylate -

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

idaman pharma sdn. bhd. - atracurium besylate -

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

imeks pharma sdn. bhd. - cisatracurium besylate -

United States - English - NLM (National Library of Medicine)

jiangsu hengrui medicine co., ltd. - cisatracurium besylate (unii: 80ys8o1mbs) (cisatracurium - unii:qx62kli41n) - cisatracurium 2 mg in 1 ml - cisatracurium besylate injection is indicated: - as an adjunct to general anesthesia to facilitate tracheal intubation in adults and in pediatric patients 1 month to 12 years of age - to provide skeletal muscle relaxation in adults during surgical procedures or during mechanical ventilation in the icu - to provide skeletal muscle relaxation during surgical procedures via infusion in pediatric patients 2 years and older limitations of use cisatracurium besylate injection is not recommended for rapid sequence endotracheal intubation due to the time required for its onset of action. cisatracurium besylate injection is contraindicated in patients with known hypersensitivity to cisatracurium. severe anaphylactic reactions to cisatracurium have been reported [see warnings and precautions ( 5.4)] . the use of 10 ml cisatracurium multiple-dose vials is contraindicated for use in pediatric patients less than 1 month of age and low birth-weight infants because the formulation contains benzyl alcohol [see warnings and